Form 8-K - Current report:
SEC Accession No. 0001297184-25-000058
Filing Date
2025-10-24
Accepted
2025-10-24 16:21:31
Documents
12
Period of Report
2025-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 1.01 amph-20251021x8k.htm   iXBRL 8-K 54619
  Complete submission text file 0001297184-25-000058.txt   166433

Data Files

Seq Description Document Type Size
2 EX-101.SCH amph-20251021.xsd EX-101.SCH 2912
3 EX-101.LAB amph-20251021_lab.xml EX-101.LAB 15360
4 EX-101.PRE amph-20251021_pre.xml EX-101.PRE 10384
14 EXTRACTED XBRL INSTANCE DOCUMENT amph-20251021x8k_htm.xml XML 4727
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 251416466
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)